Inflammatory Cells From Various Pathologies
Development of a Method to Isolate Inflammatory Cells From Skin Biopsies of Patients With Various Pathologies for Quantitative Flow Cytometry Analysis
Sponsor: Innovaderm Research Inc.
Listed as NCT02270411, this observational or N/A phase trial focuses on Acne Rosacea and Acne Vulgaris and remains completed. Sponsored by Innovaderm Research Inc., it has been updated 13 times since 2014, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Feb 2024 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Jul 2023 — Feb 2024 [monthly]
Recruiting
-
Sep 2022 — Jul 2023 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Sep 2021 — Sep 2022 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Mar 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2019 — Mar 2020 [monthly]
Recruiting
-
Sep 2018 — Sep 2019 [monthly]
Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Innovaderm Research Inc.
For direct contact, visit the study record on ClinicalTrials.gov .